BLRX

BioLineRx Ltd. BLRX

BLRX
BioLineRx Ltd. THAR
Tharimmune, Inc. GOVX
GeoVax Labs, Inc. ADAP
Adaptimmune Therapeutics plc APLM
Apollomics, Inc. ANL
Adlai Nortye Ltd. ADTX
Aditxt, Inc. MBRX
Moleculin Biotech, Inc. AIMD
Ainos, Inc. ICU
SeaStar Medical Holding Corporation

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode BLRX THAR GOVX ADAP APLM ANL ADTX MBRX AIMD ICU
6M -28.30 % 73.13 % -83.14 % -80.83 % 193.42 % 3.40 % -99.22 % -41.62 % -16.60 % -30.55 %
YTD -70.25 % 13.17 % -93.58 % -92.22 % 54.86 % -37.70 % -99.98 % -91.19 % -15.60 % -87.45 %
1Y -65.88 % 11.00 % -92.80 % -91.75 % 76.24 % -31.53 % -99.98 % -90.98 % -10.21 % -87.70 %
3Y -86.90 % -98.28 % -98.20 % -96.58 % -98.39 % -89.87 % -100.00 % -99.17 % -86.60 % -99.77 %
5Y -97.12 % -99.82 % -99.67 % -99.02 % -98.31 % -89.87 % -100.00 % -99.78 % -96.32 % -99.90 %
10Y -99.62 % -99.82 % -99.64 % -99.51 % -98.31 % -89.87 % -100.00 % -99.98 % -96.32 % -99.90 %
Depuis le début -99.91 % -99.82 % -99.64 % -99.70 % -98.31 % -89.87 % -100.00 % -99.98 % -96.32 % -99.90 %

Dividende